Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Isoleucine, Leucine, Lysine monohydrate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine, Acetylcysteine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Aminoplasmal 15% is a solution which is given to you through a small tube placed in a vein (intravenous infusion). The solution contains amino acids that are essential for the body to grow or to recover. You will receive this medicine if you are unable to eat food normally and you cannot be fed through a tube placed into your stomach either. This solution can be given to adults, adolescents and children over 2 years of age. 2.
e Aminoplasmal 15%
Do not use Aminoplasmal 15% ● if you are allergic to any of the active substances or any of the other ingredients of this medicine (listed in section 6) ● if you suffer from an inborn error of your metabolism of proteins and amino acids ● if you have a severe (i.e. life-threatening) circulation disorder (shock) ● if you have insufficient oxygen supply (hypoxia) ● if acidic substances accumulate in your blood (metabolic acidosis) ● if you have a severe liver disease (severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy grades III and IV) ● if you have severe kidney failure (severe renal insufficiency) not adequately treated by artificial kidney or similar therapies ● if you suffer from a poorly controlled heart failure with marked impairment of your blood circulation (decompensated cardiac insufficiency)
1
● ●
if you have accumulation of fluid in your lungs (acute pulmonary oedema) if your body's salt (electrolyte) or water balance is disturbed
This solution must not be given to newborn babies and children infants and toddlers less than two years of age because the composition of the solution does not properly meet the special nutrition requirements of this age group. Warnings and precautions Talk to your doctor or pharmacist before using Aminoplasmal 15%
2
This medicine is normally given to immobile patients in a controlled setting (emergency treatment, acute treatment in a hospital or a day therapy unit). This will exclude driving and using machines. Important information about some of the ingredients of Aminoplasmal 15% This medicine contains 122 mg sodium (main component of cooking/table salt) in each 1000 ml. This is equivalent to 6.1 % of the recommended maximum daily dietary intake of sodium for an adult. 3.
Aminoplasmal 15%
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Dosage Adults Your doctor will determine the amount of solution you need each day. In general, this will be 6.7 – 13.3 ml per kg of your body weight per day. The solution will flow in at a rate of not more than 0.67 ml per kg of your body weight per hour. Children from 2 to 18 years old In children the doctor will adjust the dosage carefully according to the individual child's age, status of development and actual disease. The amounts to be given will be approximately: 2 to less than 3 years old: 6.64 – 16.6 ml per kg of body weight per day 3 to 18 years old: 6.64 – 13.3 ml per kg of body weight per day For critically ill children the amount to be given may be higher (up to 20 ml per kg body weight per day). The solution will run in at a rate of not more than 0.67 ml per kg body weight per hour. Patients with kidney or liver disease The doses will be adjusted according to your individual requirements if you have liver (hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy grades I and II) or kidney disease. When given during dialysis amino acid losses into the dialysate have to be considered. Duration of use This medicine may be used as long as you need intravenous feeding. Method of administration This medicine will be administered to you through a small tube inserted into one of your large veins (central venous infusion). If you received more Aminoplasmal 15% than you should It is unlikely that this occurs because your doctor will determine your daily doses. However, if you receive an overdose or the solution is flowing too fast, you may feel sick, may have to vomit and/or have a headache. Also, your blood may contain too much ammonia (hyperammonaemia) and you may lose amino acids in the urine. You may also suffer from too much fluid in your body (hyperhydration), your body's salt balance may be disturbed (electrolyte imbalance) and you may have water on your lungs (pulmonary oedema). If this happens, the infusion will be stopped and started again at a lower infusion rate some time later.
3
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Such side effects are not specifically related to Aminoplasmal 15% but may occur with any kind of intravenous feeding, especially at the beginning. The following side effects may be serious. If any of the following side effects occur, tell your doctor immediately, he will stop giving you this medicine: Not known (frequency cannot be estimated from the available data)
Aminoplasmal 15%
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and carton labels. The expiry date refers to the last day of that month. Do not store above 30 °C. Do not freeze. Cool storage of the solution, below 15 °C, may lead to formation of crystals, that can, however, be easily dissolved by gentle warming at 25 °C until dissolution is complete. Shake container gently to ensure homogeneity. Only to be used if the solution is clear and colourless up to faintly straw-coloured and the bottle and its closure are undamaged. After infusion, any remaining solution should never be stored for later use. 6.
4
What Aminoplasmal 15% contains The active substances are amino acids. This medicine contains: Isoleucine Leucine Lysine monohydrate (equivalent to lysine) Methionine Phenylalanine Threonine Tryptophan Valine Arginine Histidine Alanine Glycine Aspartic acid Glutamic acid Proline Serine Tyrosine Acetylcysteine (equivalent to cysteine)
per 1 ml 5.850 mg 11.40 mg 8.930 mg (7.950 mg) 5.700 mg 5.700 mg 5.400 mg 2.100 mg 7.200 mg 16.05 mg 5.250 mg 22.35 mg 19.20 mg 7.950 mg 16.20 mg 7.350 mg 3.000 mg 0.500 mg 0.500 mg (0.370 mg)
per 500 ml 2.925 g 5.700 g 4.465 g (3.975 g) 2.850 g 2.850 g 2.700 g 1.050 g 3.600 g 8.025 g 2.625 g 11.175 g 9.600 g 3.975 g 8.100 g 3.675 g 1.500 g 0.250 g 0.250 g (0.185 g)
per 1000 ml 5.850 g 11.40 g 8.930 g (7.950 g) 5.700 g 5.700 g 5.400 g 2.100 g 7.200 g 16.05 g 5.250 g 22.35 g 19.20 g 7.950 g 16.20 g 7.350 g 3.000 g 0.500 g 0.500 g (0.370 g)
The other ingredients are sodium hydroxide, citric acid monohydrate (for pH-adjustment) and water for injections. Electrolyte concentrations Citrate Sodium Total amino acids Total nitrogen Energy [kJ/l (kcal/l)] Theoretical osmolarity [mOsm/l] Acidity (titration to pH 7.4) [mmol NaOH/l] pH
1.0 – 1.9 mmol/l 5.3 mmol/l 150 g/l 24.0 g/l 2505 (600) 1290 approx. 31 5.7 – 6.3
What Aminoplasmal 15% looks like and contents of the pack Aminoplasmal 15% is a clear, colourless up to faintly straw-coloured solution, practically free from visible particles.
5
The product comes in colourless glass bottles of 500 ml and 1000 ml, which are each closed by rubber stoppers. The 500 ml bottles are available in packs of 1 and 10. The 1000 ml bottles are available in packs of 1 and 6. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany Postal address 34209 Melsungen, Germany Phone: +49-5661-71-0 Fax: +49-5661-71-4567 This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (GB and NI) under the following names: France Germany Poland Spain United Kingdom (GB and NI)
AMINOPLASMAL 25, solution pour perfusion Aminoplasmal – 15 % elektrolyt- und kohlenhydratfrei AMINOPLASMAL 15 % AMINOPLASMAL B.BRAUN 15% solución para perfusión Aminoplasmal 15% solution for infusion
This leaflet was last revised in February 2026 The following information is intended for healthcare professionals only: Dosage In the case of amino acid requirements of 1.0 g per kg body weight per day or more, particular attention should be paid to the limitations of fluid input. To avoid fluid overload, amino acid solutions with higher amino acid content may have to be used in such situations. Patients with renal/hepatic impairment The doses should be adjusted individually in patients with mild to moderate renal insufficiency. The doses should be adjusted individually in patients with mild to moderate hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades I and II). When given during dialysis amino acid losses into the dialysate have to be considered. Aminoplasmal 15% is contraindicated in severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades III and IV) and severe renal insufficiency in absence of renal replacement therapy. Instructions for handling Use a sterile giving set for infusion of Aminoplasmal 15%.
6
If in the setting of complete parenteral nutrition it is necessary to add other nutrients such as carbohydrates, lipids, vitamins, electrolytes and trace elements to this medicinal product, admixing must be performed under strict aseptic conditions. Mix well after admixture of any additive. Aminoplasmal 15% can only be mixed with other nutrients for which compatibility has been documented (see section 6.6 of the SmPC). Special care must be taken when using inorganic phosphate sources: Mixtures containing inorganic phosphate are incompatible with concentrations of amino acids less than 20 g/l and glucose less than 50 g/l and should be strictly avoided. Pay special attention to compatibility. Special precaution for storage Do not store above 30 °C. The solution should only be used if the closure of the container is not damaged and if the solution is clear colourless to faintly straw-coloured, practically free from visible particles. Containers are for single use only. Discard container and any unused contents after use. Shelf life after admixture of additives From a microbiological point of view, mixtures should be administered immediately after preparation. If not administered immediately, storage times and conditions of mixtures prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 °C to 8 °C, unless mixing has taken place under controlled and validated aseptic conditions. For complete information on this medicinal product please refer to the Summary of Product Characteristics.
7
Aminoplasmal 15% Solution for Infusion comes as infusion. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Aminoplasmal 15% Solution for Infusion is isoleucine, leucine, lysine monohydrate, methionine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, alanine, glycine, aspartic acid, glutamic acid, proline, serine, tyrosine, acetylcysteine.
This leaflet reproduces the patient information leaflet approved for Aminoplasmal 15% Solution for Infusion, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Supply of amino acids for parenteral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. For adults, adolescents and children over 2 years of age.
Posology
The dosage has to be adjusted according to the individual need of amino acids and fluid, depending on the clinical condition of the patient (nutritional status and/or degree of nitrogen catabolism due to underlying disease).
Adults
Daily dose:
1.0 – 2.0 g amino acids/kg body weight
≙ 6.7 – 13.3 ml/kg body weight
≙ 469 – 931 ml for a 70 kg patient
Maximum infusion rate:
0.1 g amino acids/kg body weight/h
≙ 0.67 ml/kg body weight/h
≙ 0.78 ml/min for a 70 kg patient
Paediatric population
Newborn infants, infants and toddlers less than two years of age.
Aminoplasmal 15% is contraindicated in newborn infants, infants and toddlers less than 2 years of age (see section 4.3).
Children and adolescents 2 to 18 years
The dosages for the age groups stated below are average values for guidance. The exact dosage should be adjusted individually according to age, developmental stage and prevailing disease.
Daily dose for children 2 to less than 3 years old:
1.0 - 2.5 g amino acids/kg body weight ≙ 6.64 - 16.6 ml/kg body weight
Daily dose for children 3 to 18 years old:
1.0 - 2.0 g amino acids/kg body weight ≙ 6.64 - 13.3 ml/kg body weight
Critically ill children:
For critically ill patients the advisable amino acid intake may be higher (up to 3.0 g amino acids/kg body weight per day).
Maximum infusion rate:
0.1 g amino acids/kg body weight/h ≙ 0.67 ml/kg body weight /h
In the case of amino acid requirements of 1.0 g/kg body weight/day or more, particular attention should be paid to the limitations of fluid input. To avoid fluid overload, amino acid solutions with higher amino acid content may have to be used in such situations.
Patients with renal/hepatic impairment
The doses should be adjusted individually in patients with hepatic or renal insufficiency (see also section 4.4). When given during dialysis amino acid losses into the dialysate have to be considered. Aminoplasmal 15% is contraindicated in severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades III and IV) and severe renal insufficiency in absence of renal replacement therapy (see section 4.3).
Duration of use
This solution can be administered as long as parenteral nutrition is indicated.
Method of administration
Intravenous use.
For central venous infusion only.
● Hypersensitivity to the active substances or to any of the excipients listed in section 6.1
● Inborn errors of amino acid metabolism
● Severe circulation disorders with vital risk (e.g. shock)
● Hypoxia
● Metabolic acidosis
● Severe hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades III and IV)
● Severe renal insufficiency in absence of renal replacement therapy
● Decompensated cardiac insufficiency
● Acute pulmonary oedema
● Disturbances of the electrolyte and fluid balance
The medicinal product must not be administered to newborn infants, infants and toddlers less than two years of age, because the amino acid composition does not properly meet the special requirements of this paediatric age group.
The medicinal product should only be administered after careful benefit-risk assessment in the presence of disorders of amino acid metabolism of other origin than stated under section 4.3.
Care should be exercised in the administration of large volume infusion fluids to patients with cardiac insufficiency.
Caution should be exercised in patients with increased serum osmolarity.
Disturbances of fluid and electrolyte balance (e.g. hypotonic dehydration, hyponatraemia, hypokalaemia) should be corrected prior to the administration of parenteral nutrition.
Serum electrolytes, blood glucose, fluid balance, acid-base balance and renal function should be monitored regularly.
Monitoring should also include serum protein and liver function tests.
Renal impairment
In patients with renal insufficiency, the dose must be carefully adjusted according to individual needs, severity of organ insufficiency and the kind of instituted renal replacement therapy (haemodialysis, haemofiltration etc.). Amino acid losses due to the dialysis procedure had to be taken into consideration when adjusting the dose.
Hepatic impairment
In patients with hepatic insufficiency or decompensated liver cirrhosis with hepatic encephalopathy (grades I and II), the dose must be carefully adjusted according to individual needs and severity of organ insufficiency.
Amino acid solutions are only one component of parenteral nutrition. For complete parenteral nutrition, substrates for non-protein energy supply, essential fatty acids, electrolytes, vitamins, fluids and trace elements must be administered together with amino acids.
This medicinal product contains approximately 122 mg sodium (5.3 mmol) per 1000 ml, corresponding to 6.1% of the WHO adult recommended maximum daily sodium intake of 2 g. This should be kept in mind when administering the product to patients requiring dietary restriction of sodium.
None known. For information on incompatibilities, see section 6.2.
Pregnancy
There are no data from the use of Aminoplasmal 15% in pregnant women. No animal reproductive studies have been performed with Aminoplasmal 15%. The use of Aminoplasmal 15% may be considered during pregnancy, if necessary. Aminoplasmal 15% should only be given to pregnant women after careful consideration.
Breast-feeding
Amino acids/metabolites are excreted in human milk, but at therapeutic doses of Aminoplasmal 15% no harmful effects on the breastfed newborn/infant are anticipated.
Nevertheless, breast-feeding is not recommended for mothers on parenteral nutrition.
Fertility
No data available.
Not relevant
Undesirable effects that, however, are not specifically related to the product but to parenteral nutrition in general may occur, especially at the beginning of parenteral nutrition.
Undesirable effects are listed according to their frequencies as follows:
Very common (≥ 1/10)
Common (≥ 1/100 to < 1/10)
Uncommon (≥ 1/1,000 to < 1/100)
Rare (≥ 1/10,000 to < 1/1,000)
Very rare (< 1/10,000)
Not known (cannot be estimated from the available data)
Immune system disorders
Not known: Allergic reactions
Gastrointestinal disorders
Uncommon: Nausea, vomiting
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms of fluid overdose
Overdose or too high infusion rates may lead to hyperhydration, electrolyte imbalance and pulmonary oedema.
Symptoms of amino acid overdose
Overdose or too high infusion rates may lead to intolerance reactions manifesting in the form of nausea, vomiting, headache, hyperammonaemia and renal amino acid losses.
Treatment
If intolerance reactions occur, the amino acid infusion must be interrupted temporarily and resumed later on at a lower infusion rate.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Not the same combination. This medicine contains Isoleucine, Leucine, Lysine monohydrate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine, Acetylcysteine. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Isoleucine, Leucine, Lysine monohydrate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Aspartic acid, Glutamic acid, Proline, Serine, Tyrosine, Acetylcysteine. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Aminoplasmal 15% Solution for Infusion. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.